Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Danaher Corporation

DHR-PB•NYSE
Healthcare
Medical - Diagnostics & Research
$1261.26
$-9.94(-0.78%)
U.S. Market is Open • 10:40

Danaher Corporation (DHR-PB) Stock Overview

Explore Danaher Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap916.8B
P/E Ratio41.10
EPS (TTM)$8.64
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$1900.80

DHR-PB Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Danaher Corporation (DHR-PB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $1900.80.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 41.10 and a market capitalization of 916.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-0.00%
3-Month Change
-3.51%
6-Month Change
-7.27%
Year-to-Date (YTD) Change
-6.08%
1-Year Change
1.12%
3-Year Change
41.16%
5-Year Change
40.18%
All-Time (Max) Change
40.18%

Contact Information

https://www.danaher.com
202 828 0850
2200 Pennsylvania Avenue, NW, Washington, DC, 20037-1701

Company Facts

790,000 Employees
IPO DateMay 11, 2020
CountryUS

Frequently Asked Questions